A systematic review of circulating IP-10/CXCL10 in patients with Plasmodium infections in relation to disease severity
2024

Review of IP-10 Levels in Malaria Patients

Sample size: 26 publication Evidence: moderate

Author Information

Author(s): Manas Kotepui, Aongart Mahittikorn, Frederick Ramirez Masangkay, Kwuntida Uthaisar

Primary Institution: Nakhon Phanom University, Thailand

Hypothesis

What is the relationship between IP-10 levels and disease severity in patients with Plasmodium infections?

Conclusion

IP-10 levels are generally elevated in patients with Plasmodium infections, but findings regarding its association with severe malaria vary across studies.

Supporting Evidence

  • IP-10 levels are elevated in patients with Plasmodium infections compared to healthy controls.
  • Most studies reported that increased IP-10 levels were associated with increased disease severity.
  • Variability in findings highlights the need for further comprehensive studies.

Takeaway

This study looks at a chemical called IP-10 in people with malaria. It found that IP-10 is usually higher in sick people, but sometimes it doesn't show a clear pattern.

Methodology

A systematic review was conducted, analyzing 26 studies on IP-10 levels in malaria patients, using literature searches across multiple databases.

Potential Biases

Potential for bias due to variability in study design, data collection, and analysis.

Limitations

Variability in findings regarding IP-10 levels and malaria severity, limited number of studies reporting quantitative data, and potential confounding factors not adequately controlled.

Participant Demographics

Most studies involved children and adults, with a significant number focusing on pregnant women.

Digital Object Identifier (DOI)

10.1038/s41598-024-82712-0

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication